江中药业: 监事会关于公司第二期限制性股票激励计划首次授予激励对象名单（授予日）的核查意见

Core Points - The company has conducted a review of the first grant of the second phase of its restricted stock incentive plan, confirming compliance with relevant laws and regulations [1][2] - The incentive plan includes 168 eligible participants, comprising senior management, middle management, research and business key personnel [2] - The grant date is set for May 16, 2025, with a total of 6.217 million shares to be granted at a price of 13.70 yuan per share [2] Summary by Sections - Eligibility Criteria: The review confirmed that the selected incentive recipients do not fall under any disqualifying conditions as outlined by the relevant laws and regulations [1][2] - Exclusions: Independent directors, supervisors, and shareholders holding more than 5% of the company's shares are excluded from the incentive plan [2] - Grant Conditions: The conditions for granting the incentive have been met, and the supervisory board has approved the plan [2]